Table of Content - Critical Limb Ischemia Treatment Market

Global critical limb ischemia treatment market refers to the medical condition where the blood circulation to extremities like legs is severely reduced. This is a serious condition that can lead to amputation if left untreated. The condition arises due to the accumulation of fatty substances in arteries leading to atherosclerosis. The limited blood flow leads to severe pain and sores on extremities which do not heal. The global critical limb ischemia treatment market is poised to grow significantly in the coming years due to increasing geriatric population, rising cases of peripheral artery diseases, and growing awareness regarding available treatment options.

Market Dynamics:

The global critical limb ischemia treatment market is driven by the rising prevalence of diabetes and growing geriatric population globally which are major risk factors for CLI. Additionally, increasing research funding for the development of advanced treatment devices and drugs is also boosting the market growth. However, high cost of angioplasty and vascular surgeries hampers patient’s accessibility to treatment. Growing awareness about CLI and availability of reimbursement coverage in developed nations provides lucrative opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global critical limb ischemia treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global critical limb ischemia treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Boston Scientific, Cardinal Health, Terumo, Abbott Laboratories, etc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global critical limb ischemia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global critical limb ischemia treatment market

Detailed Segmentation-

By Drugs
- Antihypertensive Agents
- Antiplatelet Drugs
- Antithrombotic Agents
- Lipid-lowering Agents
- Others
By Route of administration
- Oral
- Parentral
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Nursing Homes
- Others (Rehabilitation Centers, etc.)
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Cook Medical Inc.
- Cardiovascular Systems, Inc.
- Philips Healthcare
- Braun Melsungen AG
- Terumo Corporation
- Biotronik SE & Co. KG
- Cordis Corporation
- Smith & Nephew plc
- Stryker Corporation
- AngioDynamics, Inc.
- GE Healthcare
- Sanofi S.A.
- AstraZeneca plc
- Bristol-Myers Squibb Company

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drugs
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Critical Limb Ischemia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
Global Critical Limb Ischemia Treatment Market, By Drugs, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Antihypertensive Agents
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Antiplatelet Drugs
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Antithrombotic Agents
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Lipid-lowering Agents
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Critical Limb Ischemia Treatment Market, By Route of Administration 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Oral
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Parentral
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Critical Limb Ischemia Treatment Market, By End User, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Hospitals
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Specialty Clinics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Ambulatory Surgery Centers
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Nursing Homes
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Critical Limb Ischemia Treatment Market, By Region, 2019 – 2031, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Region, 2019–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Advanced Brain Monitoring, Inc.
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Medtronic plc
    - Boston Scienti Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - fic Corporation
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Abbott Laboratories
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Cook Medical Inc.
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Cardiovascular Systems, Inc.
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Philips Healthcare
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - B. Braun Melsungen AG
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Terumo Corporation
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Biotronik SE & Co. KG
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Cordis Corporation
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Smith & Nephew plc
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Stryker Corporation
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - AngioDynamics, Inc.
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - GE Healthcare
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sanofi S.A.
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - AstraZeneca plc
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bristol-Myers Squibb Company
    - Company Highlights
    - Drugs Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
Reference and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Critical Limb Ischemia Treatment Market” - Global forecast to 2031

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now